Perspectives of healthcare providers on implementation of long‐acting cabotegravir plus rilpivirine in US healthcare settings from a Hybrid III Implementation‐effectiveness study (CUSTOMIZE)

Czarnogorski, Maggie; Garris, Cindy; Dalessandro, Marybeth; D’Amico, Ronald; Nwafor, Toyin; Williams, Will; Merrill, Deanna; Wang, Yuanyuan; Stassek, Larissa; Wohlfeiler, Michael; Sinclair, Gary; Mena, Leandro; Thedinger, Blair; Flamm, Jason; Benson, Paul; Spreen, William

doi:10.1002/jia2.26003

Public

Perspectives of healthcare providers on implementation of long‐acting cabotegravir plus rilpivirine in US healthcare settings from a Hybrid III Implementation‐effectiveness study (CUSTOMIZE)

Published in Journal of the International AIDS Society • Sep 1, 2022

Authors:

Maggie Czarnogorski

Cindy Garris

Marybeth Dalessandro

Abstract

INTRODUCTION: CUSTOMIZE evaluated the implementation of long-acting (LA) cabotegravir + rilpivirine, a novel healthcare provider-administered injectable antiretroviral therapy regimen, in diverse US healthcare settings. Findings from staff-study participants (SSPs) through 12 months of implementatio...

Subject

Rilpivirine

Medicine

Health care

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!